hepurposeofthisreportwastoupdatethe2006InternationalLeagueAgainstEpilepsy(ILAE)reportandidentifythelevelofevidenceforlong-termefficacyoreffectivenessforantiepilepticdrugs(AEDs)asinitialmonotherapyforpatientswithnewlydiagnosedoruntreatedepilepsy.AllapplicablearticlesfromJuly2005untilMarch2012wereidentified,evaluated,andcombinedwiththepreviousysis(Glauseretal.,2006)toprovideacomprehensiveupdate.
Thepriorysismethodologywasutilizedwiththreemodifications:(1)thedetectablenoninferiorityboundaryapproachwasdroppedandbothfailedsuperioritystudiesandprespecifiednoninferioritystudieswereyzedusinganoninferiorityapproach,(2)thedefinitionofanadequatecomparatorwasclarifiedandnowincludesanabsoluteminimumpointestimateforefficacy/effectiveness,and(3)therelationshiptablebetweenclinicaltrialratings,levelofevidence,andconclusionsnolongerincludesarecommendationcolumntoreinforcethatthisreviewofefficacy/evidenceforspecificseizuretypesdoesnotimplytreatmentrecommendations.
Thisevidencereviewcontainsoneclarification:ThecommissionhasdeterminedthatclassIsuperioritystudiescanbedesignedtodetectuptoa20?solute(ratherthanrelative)differenceinthepointestimateofefficacy/effectivenessbetweenstudytreatmentandcomparatorusinganintent-to-treatysis.SinceJuly,2005,threeclassIrandomizedcontrolledtrials(RCT)and11classIIIRCTshebeenpublished.Thecombinedysis(1940-2012)nowincludesatotalof64RCTs(7withclassIevidence,2withclassIIevidence)and11meta-yses.
Newefficacy/effectivenessfindingsincludethefollowing:levetiracetamandzonisamidehelevelAevidenceinswithpartialonsetseizuresandbothethosuximideandvalproicacidhelevelAevidenceinchildrenwithchildhoodabsenceepilepsy.
Therearenomajorchangesinthelevelofevidenceforanyothersubgroup.LevetiracetamandzonisamidejoincarbamazepineandphenytoinwithlevelAefficacy/effectivenessevidenceasinitialmonotherapyforswithpartialonsetseizures.AlthoughethosuximideandvalproicacidnowhelevelAefficacy/effectivenessevidenceasinitialmonotherapyforchildrenwithabsenceseizures,therecontinuestobeanalarminglackofwelldesigned,properlyconductedepilepsyRCTsforpatientswithgeneralizedseizures/epilepsiesandinchildreningeneral.
Thesefindingsreinforcetheneedformulticenter,multinationaleffortstodesign,conduct,andyzefutureclinicallyrelevantadequatelydesignedRCTs.Whenselectingapatient'sAED,allrelevantvariablesandnotjustefficacyandeffectivenessshouldbeconsidered.
查看信源地址
编辑:jiang上一页:癫痫患者手术评估新型工具
下一页:隐源性癫痫死亡率少于
- 2022-04-28老年癫痫头痛有哪些症状表现
- 2022-04-26癫痫孕妇使用抗癫痫药物才会增加流产风险吗?
- 2022-04-132013国际抗癫痫联合会抗癫痫药用指南
- 2022-04-12癫痫患者手术评估新型工具
- 2022-04-11UCB的Vimpat癫痫新适应症在美国获批
- 2022-04-07癫痫治疗障碍仍难以克服
- 2013国际抗癫痫联合会抗癫痫药用指南
- 癫痫患者手术评估新型工具
- UCB的Vimpat癫痫新适应症在美国获批
- 癫痫治疗障碍仍难以克服
- 癫痫发作对中风患者静脉溶栓的长期转移有效
- FDA批准Aptiom用于治疗患者癫痫发作
- PLoS ONE:新的合成蛋白能快速激活免疫系统抵抗流感
- 药学版元宵灯谜 看你能猜对几个问题
- 为什么要定期复查脑电图?
- 男人的寿命与做这件事的频率有关
- NeuroImage:纤维球成像可用于癫痫的进展
- 预测癫痫患者再入院风险
- 通过尿色自测健康状况(7)
- 简单而不简单的疾病:经典输尿管结石 1 病例
- 罕见病例:自发性颞极性扩张伴癫痫发作
- 如果你想生**,你必须知道这些事情!
- 雷安平主任白癜风医院:白癜风病情变化会有什么症状?
- 月经期间要注意 有些药物和食物不能食用
- 2015 神经系统疾病诊疗进展
- 常见妇科炎症的相关问答
- 患者饮食注意事项
- Diabetes Obes Metab:恩格列净对肝脂肪变性和纤维化标志物的影响及其与心肾结局的关系
- 癫痫猝死:凶手是谁?
- 综述:癫痫持续状态诊治最新进展
- 诺华Cosentyx欧盟批准治疗中重度斑块状银屑病
- 世界癫痫日 | 科学防治 标准诊疗 告别癫痫
- 月经性癫痫患者妊娠期癫痫控制更好
- 长期熬夜、沉迷网游竟会肇因癫痫?这些不良习惯真的要改改了
- 治疗癫痫病的种系统有哪些
- 孩童癫痫病的治疗
- 北京治疗癫痫病哪最出色
- 癫痫频繁发作伤害极大,如何减少癫痫频发? 在生活中中这样做!
- 病患癫痫病的医院哪家好
- 为治癫痫困窘,可发作越来越频繁?究其原因竟然是因为这个!
- 癫痫病症如何合理更换药物
- 昆明男童突发癫痫致1岁儿子重度烧伤,居家外出应警惕这危险因素
- 得了癫痫该怎么办 用药癫痫病的用药方法
- 昆明女子突发癫痫致1岁儿子重度烧伤,整天外出应警惕这危险因素
- 记好癫痫回忆录,让就诊事半功倍
- 继发性癫痫能治好吗